Position in ARGX
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$23,101,458
-$8,562,832 QoQ
Shares Held
31,635
-16.0% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
3.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Tri Locum Partners LP holds $302,334,342 across 10 Biotechnology names. ARGX ranks #6 (7.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
255,332 | $58,402,088 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,314 | $57,743,873 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
103,288 | $54,068,169 | |
| 4 | NUVL |
Nuvalent, Inc.
|
308,506 | $31,606,439 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
158,663 | $29,995,240 | |
| 6 | ARGX |
Argenx SE
This page
|
31,635 | $23,101,458 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
252,588 | $17,719,048 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
145,543 | $12,213,968 |
All Filings in ARGX
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $23,101,458 | 31,635 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $31,664,290 | 37,653 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $32,018,217 | 43,411 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $26,344,457 | 47,793 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $10,561,239 | 17,844 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $35,828,670 | 58,258 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $33,865,905 | 62,474 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $32,062,922 | 74,558 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,016,679 | 27,981 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,199,558 | 24,182 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,052,923 | 14,346 | Shares | Sole | 2023-11-14 | |
| 2022-12-31 | $492,100 | 1,299 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,648,863 | 64,152 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $31,346,636 | 82,735 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,313,322 | 35,880 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,930,635 | 48,347 | Shares | Sole | 2022-02-14 | |
| 2021-06-30 | $1,929,256 | 6,408 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||